Back to top
more

Shockwave Medical Inc. (SWAV)

(Delayed Data from NSDQ)

$43.43 USD

43.43
437,633

+2.29 (5.57%)

Updated May 3, 2019 04:00 PM ET

After-Market: $43.32 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

3 Reasons to Hold Abiomed (ABMD) Stock in Your Portfolio

by Zacks Equity Research

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.

The Zacks Analyst Blog Highlights Marathon Petroleum, Ulta Beauty, HF Sinclair, ShockWave Medical and Paylocity

by Zacks Equity Research

Marathon Petroleum, Ulta Beauty, HF Sinclair, ShockWave Medical and Paylocity are part of The Zacks top Analyst Blog.

Veeva Systems (VEEV) Beats on Q2 Earnings, Revises FY23 View

by Zacks Equity Research

Veeva Systems' (VEEV) fiscal Q2 results reflect impressive performances by both of its segments.

Zacks Industry Outlook Highlights ShockWave Medical, Semler Scientific and Asensus Surgical

by Zacks Equity Research

ShockWave Medical, Semler Scientific and Asensus Surgical are part of Zacks Industry Outlook article.

How to Find Strong Buy Medical Stocks Using the Zacks Rank

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.

Nalak Das headshot

Top 5 Momentum Stocks to Brace for a Scary September

by Nalak Das

We have narrowed our search to five large-cap momentum stocks that have solid upside left for September. These are: SWAV, PCTY, DINO, MPC and ULTA.

Urmimala Biswas headshot

3 Medical Instruments Stocks to Buy Despite Industry Headwinds

by Urmimala Biswas

The Zacks Medical - Instruments industry is growing on R&D investments. SWAV, SMLR and ASXC are set to gain the most. Yet, the ongoing inflation in the form of rising freight, raw material and labor costs is disrupting the trend.

Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for IWO

Catalent (CTLT) Q4 Earnings Beat Estimates, Revenues Lag

by Zacks Equity Research

Catalent's (CTLT) robust performance across most of its segments drives its fourth-quarter fiscal 2022 top line.

Veeva Systems (VEEV) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research

Veeva Systems' (VEEV) Q2 earnings are likely to have been driven by strength in its commercial business.

Catalent (CTLT) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Catalent's (CTLT) Q4 results are likely to have been driven by robust segmental performances.

3 Reasons to Add AMN Healthcare (AMN) Stock to Your Portfolio

by Zacks Equity Research

Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.

Here's Why You Should Buy ShockWave Medical (SWAV) Stock

by Zacks Equity Research

ShockWave Medical (SWAV) continues to benefit from solid R&D efforts and commitment to clinical studies.

LHC Group (LHCG) to Expand Access in Georgia With New Buyout

by Zacks Equity Research

LHC Group (LHCG) is set to acquire Georgia-based Three Rivers Home Health that will expand its service footprint in 36 counties in the state of Georgia.

DENTSPLY SIRONA (XRAY) Falls After Nasdaq's Delinquency Notice

by Zacks Equity Research

The Nasdaq exchange issues a notice to DENTSPLY SIRONA (XRAY) for filing delinquency from the exchange and for non-compliance with the Nasdaq Listing Rules. Shares fall.

Here's Why Shockwave Medical (SWAV) is a Great Momentum Stock to Buy

by Zacks Equity Research

Does Shockwave Medical (SWAV) have what it takes to be a top stock pick for momentum investors? Let's find out.

Here's Why You Should Buy Patterson Companies (PDCO) Stock

by Zacks Equity Research

Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.

Can Shockwave Medical (SWAV) Run Higher on Rising Earnings Estimates?

by Zacks Equity Research

Shockwave Medical (SWAV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Cardinal Health (CAH) Q4 Earnings Lag Estimates, Revenues Top

by Zacks Equity Research

Cardinal Health's (CAH) fiscal fourth-quarter results benefit from a solid performance in the Pharmaceutical segment.

Catalent (CTLT) to Acquire New CDMO Facility for $475 Million

by Zacks Equity Research

Catalent (CTLT) agrees to buy Mayne Pharma's specialty CDMO division, Metrics Contract Services, for $475 million. The deal is expected to be completed by 2022-end.

CONMED (CNMD) Acquires Soft Tissue Implant Start-Up Biorez

by Zacks Equity Research

CONMED (CNMD) acquires privately-held Biorez, Inc. for $85 million. The deal is set to boost CONMED's sports medicine portfolio with the addition of Biorez's proprietary BioBrace Implant technology.

Shockwave Medical (SWAV) Beats on Q2 Earnings & Revenues

by Zacks Equity Research

Shockwave Medical's (SWAV) second-quarter results reflect robust revenue growth and expansion in gross margin.

DENTSPLY SIRONA (XRAY) Up on Strong Q2 Preliminary Results

by Zacks Equity Research

DENTSPLY SIRONA's (XRAY) preliminary second-quarter 2022 results reflect the normalizing business, aided by product launches and pricing adjustments. Shares rise.

Shockwave Medical (SWAV) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 58.14% and 12.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Assertio (ASRT) and Shockwave Medical (SWAV) have performed compared to their sector so far this year.